EMS-CHEMIE (EMSN) Q1 2025 earnings summary

Executive summary

• Net sales for Q1 2025 reached CHF 522 million, down from CHF 545 million year-over-year due to lower prices and costs, but new business offset weak demand.

• Global economic slowdown, trade barriers, and tariffs impacted performance, but EMS adapted supply chains and maintained profitability.

• No direct China-USA trade exposure; US sales are locally produced or exempt from tariffs.

Financial highlights

• Net sales decreased 4.3% year-over-year to CHF 522 million.

• High Performance Polymers net sales fell 4.9% to CHF 469 million; Specialty Chemicals grew 1.9% to CHF 52 million.

• Currency effects had a minor positive impact on reported figures.

Outlook and guidance

• 2025 expected to remain challenging due to trade conflicts, inflation, and restructuring in key markets.

• Net sales for 2025 projected below previous year, mainly from currency effects; EBIT expected slightly above previous year.

• Focus remains on growth through innovation and specialties, leveraging local partnerships and global supply.